Medicamen Biotech has informed that it enclosed the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, received by the company from Growel Remedies for sale of equity share.
The above information is a part of company’s filings submitted to BSE.